Skip to content
value.today

Spineology Inc.

Total raised
$60 M
5 rounds on record
Latest round
$13 M
Nov 2025
First round on record
Aug 2016
Today
Private
No later event on record

Funding rounds

5 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Spineology Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Nov 2025$13 MNo. 5$10 to $50 million

Spineology Inc.: Raise no. 5, Nov 2025

Investors in this round

11 investors had bought by the notice of Jun 17, 2026: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$13 M of $14 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brian Snider · Executive Officer, Director
  • Steve Nemitz · Executive Officer
  • Antony Robert Koblish · Director
  • Carter McNabb · Director
  • Craig Robert Matturro · Director
  • Greg Robert Madden · Director
  • J. Robert Paulson · Director
  • Thomas Robert Patton · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Steve Nemitz, Chief Financial Officer. Source: SEC Form D and 1 amendment, newest notice filed Jun 17, 2026. Read the notice at the SEC.

equity, optionsSEC
Jul 2024$25 MNo. 4$10 to $50 million

Spineology Inc.: Raise no. 4, Jul 2024

Investors in this round

33 investors had bought by the notice of Aug 6, 2024: 33 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$25 M of $25 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and finders' fees and payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brian Robert Snider · Executive Officer, Director
  • Jamison Robert Young · Executive Officer
  • Carter Robert Mcnabb · Director
  • Craig Robert Matturo · Director
  • Greg Madden · Director
  • J. Robert Paulson · Director
  • Thomas Robert Patton · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jamison Young, Chief financial officer. Source: SEC Form D, newest notice filed Aug 6, 2024. Read the notice at the SEC.

equitySEC
Apr 2023$5 MNo. 3$2 to $10 million

Spineology Inc.: Raise no. 3, Apr 2023

Investors in this round

2 investors had bought by the notice of May 5, 2023: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $7 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jamison Young · Executive Officer
  • John Booth · Executive Officer, Director
  • Carter McNabb · Director
  • Dick Nigon · Director
  • Donald Brattain · Director
  • Ed Spencer · Director
  • James Rybicki · Director
  • Phil Soran · Director
  • Robert Paulson · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jamison Young, Cfo. Source: SEC Form D, newest notice filed May 5, 2023. Read the notice at the SEC.

debt, optionsSEC
Sep 2019$7 MNo. 2$2 to $10 million

Spineology Inc.: Raise no. 2, Sep 2019

Investors in this round

1 investor had bought by the notice of Oct 2, 2019: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $16 M offered; $9 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$420,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • John J. Booth · Executive Officer, Director
  • Carter Robert McNabb · Director
  • Dick R. Nigon · Director
  • Donald R. Brattain · Director
  • Ed T. Spencer, Jr. · Director
  • J. Robert Paulson · Director
  • James T. Rybicki · Director
  • Phil Robert Soran · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Canaccord Genuity LLC · broker-dealer Canaccord Genuity LLC (CRD 1020) · San Francisco, CaliforniaSold in OH

Signed by John J. Booth, Chief Executive Officer. Source: SEC Form D, newest notice filed Oct 2, 2019. Read the notice at the SEC.

equitySEC
Aug 2016$10 MNo. 1$10 to $50 million

Spineology Inc.: Raise no. 1, Aug 2016

Investors in this round

80 investors had bought by the notice of Aug 18, 2017: 80 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $10 M offered
Smallest investment taken
$25,000
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
$25 million to $100 million
Sales commissions
$472,550
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Minnesota

People named in the notice

  • John J. Booth · Executive Officer, Director
  • Donald R. Brattain · Director
  • Edson W. Spencer · Director
  • James T. Rybicki · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • James D. Kallstrom (CRD 2498681) · broker-dealer The Oak Ridge Financial Services Group, Inc. (CRD 42941) · Golden Valley, MinnesotaSold in MN, SD
  • Ryan C. McEnerney (CRD 2713356) · broker-dealer The Oak Ridge Financial Services Group, Inc. (CRD 42941) · Golden Valley, MinnesotaSold in MN, SD
  • Scott W. Rickford (CRD 2586752) · broker-dealer The Oak Ridge Financial Services Group, Inc. (CRD 42941) · Golden Valley, MinnesotaSold in MN
  • Brian R. Trygstad (CRD 1056358) · broker-dealer The Oak Ridge Financial Services Group, Inc. (CRD 42941) · Golden Valley, MinnesotaSold in MN
  • Thomas P. Hackl (CRD 3075360) · broker-dealer Dougherty & Company LLC (CRD 7477) · Minneapolis, MinnesotaSold in WA
  • Thomas P. Niemiec (CRD 348167) · broker-dealer The Oak Ridge Financial Services Group, Inc. (CRD 42941) · Golden Valley, MinnesotaSold in MN, WI
  • Randy L. Hines (CRD 1391716) · broker-dealer Dougherty & Company LLC (CRD 7477) · Minneapolis, MinnesotaSold in MN
  • Jeffrey D. Jacobson (CRD 1976541) · broker-dealer Dougherty & Company LLC (CRD 7477) · Minneapolis, MinnesotaSold in MN
  • David B. Juran (CRD 2166483) · broker-dealer Dougherty & Company LLC (CRD 7477) · Minneapolis, MinnesotaSold in MN
  • Wynn R. Juran (CRD 262745) · broker-dealer Dougherty & Company LLC (CRD 7477) · Minneapolis, MinnesotaSold in FL
  • Thomas C. Olander (CRD 2287413) · broker-dealer Dougherty & Company LLC (CRD 7477) · Minneapolis, MinnesotaSold in MN, SD
  • Jeffrey A. Schachtman (CRD 4818907) · broker-dealer The Oak Ridge Financial Services Group, Inc. (CRD 42941) · Golden Valley, MinnesotaSold in MN
  • Roman Gadaskin (CRD 2219368) · broker-dealer The Oak Ridge Financial Services Group, Inc. (CRD 42941) · Golden Valley, MinnesotaSold in MN
  • Fredrick J. Olson (CRD 1425609) · broker-dealer The Oak Ridge Financial Services Group, Inc. (CRD 42941) · Golden Valley, MinnesotaSold in MN
  • James L. Melby (CRD 1251590) · broker-dealer The Oak Ridge Financial Services Group, Inc. (CRD 42941) · Golden Valley, MinnesotaSold in MN

Remarks in the notice

  • On the use of proceeds: “Excludes standard compensation for officers.”

Signed by John J. Booth, Chief Executive Officer. Source: SEC Form D and 2 amendments, newest notice filed Aug 18, 2017. Read the notice at the SEC.

debt, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Spineology Inc. chose not to state its revenue in its newest notice of a funding round (Jun 2026).

    SEC Form D · Jun 2026

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jun 2026

That is all the official record says: Spineology Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Spineology Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 80 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Spineology Inc.
NameRoleNamed in
Brian SniderExecutive officerJun 2026
Steve NemitzExecutive officerJun 2026
Brian Robert SniderExecutive officerAug 2024
Jamison Robert YoungExecutive officerAug 2024
Jamison YoungExecutive officerMay 2023
John BoothExecutive officerMay 2023
John J. BoothExecutive officerOct 2019
Antony Robert KoblishDirectorJun 2026
Brian SniderDirectorJun 2026
Carter McNabbDirectorJun 2026
Craig Robert MatturroDirectorJun 2026
Greg Robert MaddenDirectorJun 2026
J. Robert PaulsonDirectorJun 2026
Thomas Robert PattonDirectorJun 2026
Brian Robert SniderDirectorAug 2024
Carter Robert McnabbDirectorAug 2024
Craig Robert MatturoDirectorAug 2024
Greg MaddenDirectorAug 2024
Dick NigonDirectorMay 2023
Donald BrattainDirectorMay 2023
Ed SpencerDirectorMay 2023
James RybickiDirectorMay 2023
John BoothDirectorMay 2023
Phil SoranDirectorMay 2023
Robert PaulsonDirectorMay 2023
Carter Robert McNabbDirectorOct 2019
Dick R. NigonDirectorOct 2019
Donald R. BrattainDirectorOct 2019
Ed T. Spencer, Jr.DirectorOct 2019
James T. RybickiDirectorOct 2019
John J. BoothDirectorOct 2019
Phil Robert SoranDirectorOct 2019
Edson W. SpencerDirectorAug 2017